Rousselot Biomedical’s X Pure® is changing the game in purified gelatins

Gelatin has a long and varied history in medicine, going back as far as 1834. Nowadays it’s a common material used in a number of pharmaceutical and biomedical applications around the world.

Jeff Daelman, Business Development Manager at Rousselot Biomedical, speaks at BIO-Europe® 2019 in Hamburg about X-Pure®, an innovative range of purified gelatins and collagens designed explicitly for (bio)medical applications and backed by scientific data and ongoing research. Daelman describes the new range of possibilities offered to development and patient care thanks to the first complete range of highly purified gelatins and collagens containing endotoxin levels below 10 EU/g. He also describes what the functionality and quality of X-Pure bring to the biomedical industry and how biomedical players can best utilize Rousselot Biomedical’s array of products.

Watch what Jeff Daelman (Business Development Manager) at Rousselot Biomedical says: